vs
Esperion Therapeutics, Inc.（ESPR）与Texas Pacific Land Corporation（TPL）财务数据对比。点击上方公司名可切换其他公司
Texas Pacific Land Corporation的季度营收约是Esperion Therapeutics, Inc.的1.3倍（$211.6M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 13.9%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 10.2%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Texas Pacific Land Corporation（简称TPL）是一家公开上市的不动产运营企业，行政总部位于美国得克萨斯州达拉斯市。公司在得州西部20个郡拥有逾88万英亩（约3600平方公里）土地，是得州规模最大的私人土地所有者之一，前身为得克萨斯太平洋土地信托。
ESPR vs TPL — 直观对比
营收规模更大
TPL
是对方的1.3倍
$168.4M
营收增速更快
ESPR
高出129.8%
13.9%
两年增速更快
ESPR
近两年复合增速
10.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $211.6M |
| 净利润 | — | $123.3M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 70.5% |
| 净利率 | — | 58.3% |
| 营收同比 | 143.7% | 13.9% |
| 净利润同比 | — | 4.2% |
| 每股收益（稀释后） | $0.32 | $-8.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRTPL
| Q4 25 | $168.4M | $211.6M | ||
| Q3 25 | $87.3M | $203.1M | ||
| Q2 25 | $82.4M | $187.5M | ||
| Q1 25 | $65.0M | $196.0M | ||
| Q4 24 | $69.1M | $185.8M | ||
| Q3 24 | $51.6M | $173.6M | ||
| Q2 24 | $73.8M | $172.3M | ||
| Q1 24 | $137.7M | $174.1M |
净利润ESPRTPL
| Q4 25 | — | $123.3M | ||
| Q3 25 | $-31.3M | $121.2M | ||
| Q2 25 | $-12.7M | $116.1M | ||
| Q1 25 | $-40.5M | $120.7M | ||
| Q4 24 | — | $118.4M | ||
| Q3 24 | $-29.5M | $106.6M | ||
| Q2 24 | $-61.9M | $114.6M | ||
| Q1 24 | $61.0M | $114.4M |
营业利润率ESPRTPL
| Q4 25 | 50.6% | 70.5% | ||
| Q3 25 | -11.4% | 73.4% | ||
| Q2 25 | 8.6% | 76.6% | ||
| Q1 25 | -34.0% | 76.6% | ||
| Q4 24 | -6.4% | 76.7% | ||
| Q3 24 | -31.0% | 73.4% | ||
| Q2 24 | 3.5% | 77.3% | ||
| Q1 24 | 52.5% | 78.1% |
净利率ESPRTPL
| Q4 25 | — | 58.3% | ||
| Q3 25 | -35.9% | 59.7% | ||
| Q2 25 | -15.4% | 61.9% | ||
| Q1 25 | -62.2% | 61.6% | ||
| Q4 24 | — | 63.7% | ||
| Q3 24 | -57.2% | 61.4% | ||
| Q2 24 | -83.9% | 66.5% | ||
| Q1 24 | 44.3% | 65.7% |
每股收益（稀释后）ESPRTPL
| Q4 25 | $0.32 | $-8.59 | ||
| Q3 25 | $-0.16 | $5.27 | ||
| Q2 25 | $-0.06 | $5.05 | ||
| Q1 25 | $-0.21 | $5.24 | ||
| Q4 24 | $-0.14 | $5.14 | ||
| Q3 24 | $-0.15 | $4.63 | ||
| Q2 24 | $-0.33 | $4.98 | ||
| Q1 24 | $0.34 | $4.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $144.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $1.5B |
| 总资产 | $465.9M | $1.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRTPL
| Q4 25 | $167.9M | $144.8M | ||
| Q3 25 | $92.4M | $531.8M | ||
| Q2 25 | $86.1M | $543.9M | ||
| Q1 25 | $114.6M | $460.4M | ||
| Q4 24 | $144.8M | $369.8M | ||
| Q3 24 | $144.7M | $533.9M | ||
| Q2 24 | $189.3M | $894.7M | ||
| Q1 24 | $226.6M | $837.1M |
股东权益ESPRTPL
| Q4 25 | $-302.0M | $1.5B | ||
| Q3 25 | $-451.4M | $1.4B | ||
| Q2 25 | $-433.5M | $1.3B | ||
| Q1 25 | $-426.2M | $1.2B | ||
| Q4 24 | $-388.7M | $1.1B | ||
| Q3 24 | $-370.2M | $1.1B | ||
| Q2 24 | $-344.2M | $1.2B | ||
| Q1 24 | $-294.3M | $1.1B |
总资产ESPRTPL
| Q4 25 | $465.9M | $1.6B | ||
| Q3 25 | $364.0M | $1.5B | ||
| Q2 25 | $347.1M | $1.4B | ||
| Q1 25 | $324.0M | $1.4B | ||
| Q4 24 | $343.8M | $1.2B | ||
| Q3 24 | $314.1M | $1.2B | ||
| Q2 24 | $352.3M | $1.3B | ||
| Q1 24 | $373.1M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $113.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.92× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRTPL
| Q4 25 | $45.2M | $113.7M | ||
| Q3 25 | $-4.3M | $154.6M | ||
| Q2 25 | $-31.4M | $120.9M | ||
| Q1 25 | $-22.6M | $156.7M | ||
| Q4 24 | $-35.0M | $126.6M | ||
| Q3 24 | $-35.3M | $118.6M | ||
| Q2 24 | $-7.2M | $98.3M | ||
| Q1 24 | $53.8M | $147.2M |
自由现金流ESPRTPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
自由现金流率ESPRTPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
资本支出强度ESPRTPL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ESPRTPL
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 1.28× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | 1.30× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | 0.88× | 1.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
TPL
| Water Serviceand Operations Segment | $98.2M | 46% |
| Water Sales And Royalties | $60.7M | 29% |
| Produced Water Royalties | $33.5M | 16% |
| Easementand Sundry | $20.6M | 10% |
